DGX — Quest Diagnostics Balance Sheet
0.000.00%
- $19.40bn
- $25.18bn
- $9.87bn
- 91
- 48
- 94
- 92
Annual balance sheet for Quest Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,158 | 872 | 315 | 686 | 549 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,523 | 1,438 | 1,195 | 1,210 | 1,304 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 3,058 | 2,741 | 1,898 | 2,372 | 2,392 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,231 | 2,304 | 2,351 | 2,418 | 2,764 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 14,026 | 13,611 | 12,837 | 14,022 | 16,153 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,776 | 1,753 | 1,551 | 1,815 | 2,169 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 7,267 | 7,167 | 6,944 | 7,715 | 9,375 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 6,759 | 6,444 | 5,893 | 6,307 | 6,778 |
Total Liabilities & Shareholders' Equity | 14,026 | 13,611 | 12,837 | 14,022 | 16,153 |
Total Common Shares Outstanding |